Ellie Collins
Richard White, COO of Oxford PharmaGenesis, was a panellist at the recent virtual workshop on ‘Artificial intelligence (AI) to accelerate discovery’, hosted by the Friends of the National Library of Medicine (FNLM) and sponsored by Oxford PharmaGenesis. He discussed emerging trends in the use of AI by the pharmaceutical industry, with a focus on how […]
Read More
Oxford PharmaGenesis has been recognized across offices worldwide with an internationally renowned UK Best WorkplacesTM award. The accreditation is thanks to colleagues who rated the leading independent HealthScience communications consultancy as ‘a great place to work’ in the Great Place to Work® 2021 survey.
Read More
Together with Pfizer Inc. and Digital Science, Oxford PharmaGenesis colleagues have co-developed an AI-based literature interrogation tool that will help researchers to identify biomarkers of emerging scientific interest in oncology.
Read More
Share this page Overview Day 1 report Day 2 report Day 3 report Day 3 key take-homes and insights Patient engagement in a post-COVID world Speakers: Alex Morton (NucleusX Consulting); Gerard Mortimer (Synaptik Digital) The global COVID-19 pandemic has increased our dependence on digital platforms for work, school, socializing and even for accessing healthcare. The […]
Read More
Part-funded by Oxford PharmaGenesis, ‘Our Big MS Adventure’ uniquely shows the impact of multiple sclerosis over 12 years, highlighting breakthroughs in treatment, and sharing emotive personal journeys.
Read More
Share this page Overview Day 1 report Day 2 report Day 3 report Day 2 key take-homes and insights Opening remarks & keynote – writing for equity & inclusion: the role of empathy in medical communications – Georgia Palmer (Project Coordinator, Oxford PharmaGenesis) Medical communications are reaching a wider audience than ever before, including diverse […]
Read More
Richard White, COO of Oxford PharmaGenesis, provides his expert insights on health economics and outcomes research (HEOR) publications and open access in a new article from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the leading global professional society for HEOR.
Read More
Share this page Overview Day 1 report Day 2 report Day 3 report Day 1 key take-homes and insights Unused vaccines can’t save lives – embracing an opportunity to overcome vaccination hesitancy in the midst of a global pandemic – Alan Cowland (Medical Writer, Oxford PharmaGenesis) The response to the COVID-19 pandemic clearly demonstrates that […]
Read More
Share this page Overview Day 1 report Day 2 report Day 3 report Oxford PharmaGenesis at the Virtual 17th Annual Meeting of ISMPP Company overview video ISMPP is a fantastic opportunity to share best practice and connect with people who share our vision for what medical publications and communications can achieve. Chris Winchester, CEO Presentations […]
Read More
Last week marked the fourth Informatics Summit from the American Medical Informatics Association (AMIA). The meeting provided a fantastic opportunity for members of our Informatics and Data Science practice to stay up to date with the latest developments in the fields of artificial intelligence (AI), natural language processing and machine learning in the context of […]
Read More